---
title: "What is ProstaScint (In-111 Capromab) 's mechanism of action of localization into metastatic prostatic carcinoma? When to do it?"
---
ProstaScint is a radiolabeled murine monoclonal antibody to prostate Membrane specific antigen (PMSA), which is highly expressed in prostate cancer. The examination is useful to show soft tissue (including nodal) metastasis from prostate carcinoma.

- order when rising PSA but negative bone scan
- localizes to SOFT TISSUE (not bone) mets
* Critical organ = LIVER

